Under construction – not a live service
Sign in
Taking people in FranceNo phase

Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty

Key facts

Who runs it
Corin
Where
Amboise, Hénin-Beaumont, and Paris, FranceSee the 4 sites
Trial code
Status
Recruiting
People taking part
368 people, planned
Started
29 Jun 2023
Expected to end
Sept 2035
Type of study
Observational
Treatments tested
  • Bipolar i and cemented stem (Océane+ or Meije)
Record updated
18 March 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Both genders
  • Adult subjects
  • Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices based on physical examination, medical history and diagnosis such as: non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis in which the acetabulum does not require replacement, treatment of non-union, femoral neck and trochanteric fractures of the proximal femur, revision of failed partial hip replacements in which the acetabulum does not require replacement
  • The subject is willing to comply with the required follow-up visits as per protocol
  • The subject, or a designated trusted person in case the subject is unable to do, has signed a Patient Informed Consent Form (PICF), specific to this study, and approved by the local EC

Who cannot take part

  • Subjects with active infection or sepsis or osteomyelitis
  • Subject with metabolic disorders which may impair bone formation or bone quality
  • Subjects in the opinion of the Investigator/ investigative team who will be unable to comply with study procedures (Examples: recent psychotic or mania disorders, alcohol, drug or substance abusers) and/or those unable for any medical or other reason to comply with study procedures/visits
  • Subjects with unsuitable or insufficient bone support preventing proper fixation of the prosthesis
  • Subject with marked bone loss or bone absorption
  • Subjects under guardianship
  • Subjects under jusicial protection

Where in France

  • Ch AmboiseAmboise, FranceContact: Vincent NOEL, MDTaking people
  • Polyclinique Henin BeaumontHénin-Beaumont, FranceContact: Vanessa GRIMAUDNo longer taking part
  • Hopital Diaconesses-Croix Saint SimonParis, FranceContact: Guillaume AUBERGER, MDNot yet recruiting
  • Hopital Saint JosephParis, FranceContact: Peter UPEX, MDTaking people

About the trial

What the trial wants to find out

This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.

The group in the trial

  • Hip hemiarthroplasty with BiPolar i and cemented stems (Meije or Oceane+)

    Subjects clinically suitable for a hip hemiarthroplasty surgery with Corin hip devices

    Treatment: Bipolar i and cemented stem (Océane+ or Meije)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Post-market Clinical Follow-up (PMCF) Study to Evaluate Clinical, Radiographic and Patient Reported Outcomes Following a Hip Hemiarthroplasty Surgery Using Corin Devices
Record updated
18 March 2026